drugset / Trial / NCT06006104
Phase 1/2 Clinical Study of HRS-4357 in Patients With Advanced Prostate Cancer
NaSingle-groupOpen-labelTreatment
Summary
The study is being conducted to evaluate the the safety, pharmacokinetics, radiation dosimetry, and preliminary efficacy of HRS-4357 injection in adult patients with advanced prostate cancer.
Timeline
- Start
- 2023-09-30
- Primary completion
- 2024-09-30
- Completion
- 2024-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS-4357 | Unknown | — | — |